Madely Health Headlines Commentary for December 14, 2009

 

Source:

Drug Combo boosts advanced breast cancer survival

Comment:

This approach to treatment applies only to HER-2 breast cancers that according to the article represents 1 in 4 breast cancers.

Related articles:

  1. Paxil interferes with tamoxifen’s efficacy combating breast cancer/Sunday House Call returns to the airwaves
  2. Estrogen-sensitive breast cancer risk reduction study finds two drugs that work but have trade-offs
  3. New evidence reevaluates breast cancer screening
  4. Promising breast cancer treatment needs supporting studies
  5. More genes linked to breast cancer risk